Taylor Swift's legal team filed the final trademark registration extension for "Reputation (Taylor's Version)" and "Taylor ...
This is Dermata's first issued U.S. patent for XYNGARI, which uses its Spongilla technology to topically treat acne -- Dermata expects to announce topline results from its STAR-1 Phase 3 XYNGARI clini ...
Diversity, equity, and inclusion (DE&I) is a philosophy that promotes the representation and involvement of individuals with ...
As companies—and more recently, courts—have struggled to address the role of artificial intelligence (AI) in innovation, legislators are embroiled ...
Robert F. Kennedy Jr., President Donald Trump’s nominee for health secretary, reportedly expressed openness to seizing drug ...
Hosted on MSN4h
What a US exit from the WHO means for global healthcareUS withdrawal from WHO means missing February’s meeting, reducing influence and hindering global health efforts.
Financial services provider United Services Automobile Association sued competitor Regions Bank in Texas federal court on ...
The first day of IPWatchdog’s PTAB Masters 2025 wrapped up with a session in which three IP luminaries weighed in on the ...
The Federal Circuit recently addressed a deceptively straightforward question: does a published U.S. patent application ...
Can-Fite BioPharma has secured a US patent for Namodenoson, its lead drug candidate, for use as an anti-obesity treatment.
Samsung Electronics has settled a lawsuit brought by Harvard University that accused it of infringing two patents covering ...
Howard Lutnick, the Wall Street executive in line to run the Commerce Department and champion tariffs in the Trump ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback